|1.||Weinhold, Niels: 1 article (01/2015)|
|2.||Foersti, Asta: 1 article (01/2015)|
|3.||Morgan, Gareth J: 1 article (01/2015)|
|4.||Goldschmidt, Hartmut: 1 article (01/2015)|
|5.||Hemminki, Kari: 1 article (01/2015)|
|6.||Seckinger, Anja: 1 article (01/2015)|
|7.||Meißner, Tobias: 1 article (01/2015)|
|8.||Hose, Dirk: 1 article (01/2015)|
|9.||Haenel, Mathias: 1 article (01/2015)|
|10.||Salwender, Hans: 1 article (01/2015)|
|2.||Breast Neoplasms (Breast Cancer)
10/01/2010 - "Intrathecal morphine at 0.3 μg/kg (LMPC), 3 μg/kg (MMPC) or 30 μg/kg (HMPC) was administered for 5 min before 120-min reperfusion following 30-min ischemia. "
08/01/2000 - "Neonatal rat cardiomyocytes were preconditioned using a buffer containing glycolytic inhibitors and low pH (minimal metabolic preconditioning; MMPC) consisting of modified Krebs buffer, 10 mM 2-deoxyglucose, and 20 mM lactate, pH 6.8, for 2 h followed by 24 h of simulated reperfusion before lethal simulated ischemia (LSI). "
|4.||Acute Radiation Syndrome
06/01/2012 - "With respect to efficacy, timing, and practicality of administration, mMPC appear to be a very promising radiation countermeasure for acute radiation syndrome among all candidate therapeutics currently under development."
06/01/2012 - "We further show that mMPC administration mitigates death from acute radiation syndrome at radiation doses of up to 15 Gy ((60)Co γ radiation, CD2F1), which are radiation exposure levels that cause mice to succumb to multi-organ failure, and determined that the dose-reduction factor of 5 million mMPC administered 24 h after irradiation of CD2F1 mice is 1.73. "
06/01/2012 - "Our results show that cryopreserved allogeneic mMPC significantly improve survival in both strains of mice irradiated with lethal doses of (60)Co γ radiation (CD2F1, 9.2 Gy) and X-ray exposures (Balb/c, 9 Gy) that are known to cause acute radiation syndrome in hematopoietic tissues. "
|5.||Radiation Injuries (Radiation Sickness)
|2.||Morphine (MS Contin)
|3.||Deoxyglucose (2 Deoxy D glucose)